Drug Database
Back to search

Netherlands· NL-ae939aec6a34

Vesanoid, zachte capsules 10 mg

A tretinoin product containing tretinoine, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC L01XF01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedVesanoid, zachte capsules 10 mgATCL01XF01REGISTER NO.NL-ae939aec6a34PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tretinoineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tretinoin is registered in 8 of 19 countries.

Countries holding a registration under ATC L01XF01 (tretinoin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search tretinoin products by name

Tretinoin · ATC L01XF01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRETINOINE
Manufacturer
Eureco-Pharma B.V.
Country
Netherlands (NL)
ATC code
L01XF01
ATC class
Tretinoin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127621//20455

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

366 interactions on record for tretinoin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tretinoin against other medicinesHow interaction checks work

Tretinoin · interactions on record

366 records

  • 29 severe
  • 101 moderate
  • 17 minor
  • 219 info

Most severe, free to view

  • Aminocaproic acidB02AA01severe
  • Tranexamic acidB02AA02severe
  • AprotininB02AB01severe
  • MipomersenC10AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tretinoin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tretinoin products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Vesanoid
  • Belgium · Vesanoid
  • Germany · Cordes Vas, Vesanoid
  • Spain · Neocare, Retirides
  • Finland · Avitcid, Vesanoid
  • France · Effederm, Ketrel
  • United Kingdom (Northern Ireland) · Tretinoin Neon Healthcare, Vesanoid
  • Croatia · Vesanoid
  • Ireland · Vesanoid
  • Italy · Tretinoina Same Savoma Medicinali, Vesanoid
  • Malta · Ketrel
  • Poland · Vesanoid
  • Portugal · Ketrel, Vesanoid
  • Slovakia · Vesanoid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c06d2168-0213-4030-bf2b-da3829d15ce0
GET /v1/drugs/c06d2168-0213-4030-bf2b-da3829d15ce0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h20455_smpc.pdf",
  "strength": null,
  "atc_label": "Tretinoin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127621",
  "excipients": [
    "GELATINE (E 441)",
    "GELE OF WITTE WAS (E901)",
    "GLYCEROL 85 PER CENT (E 422)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MANNITOL (D-) (E 421)",
    "SOJABOONOLIE (E 479b)",
    "SOJABOONOLIE, GEDEELTELIJK GEHYDREERD  (E 479b)",
    "SOJABOONOLIE, GEHYDREERD  (E 479b)",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEDEELTELIJK GEHYDROLYSEERD"
  ],
  "substances": [
    "TRETINOINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127621.pdf",
  "authorised_at": "2020/12/28",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127621//20455",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tretinoin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console